Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
The benefits of Sanofi and Regeneron's anti-inflammatory drug Dupixent set in quickly during a trial to treat "smoker's lung" and lasted for the duration of the 1-year study, French drugmaker Sanofi s

5 Things to Know Before Markets Open

07:25am, Friday, 19'th May 2023
President Biden said he was confident that negotiators would reach a deal on the debt ceiling and Fed Chair Jerome Powell is set to speak on monetary policy. Here's what investors need to know today.
Sanofi said Friday its shot significantly reduced the risk of babies becoming hospitalized with RSV. The results could stoke Sanofi stock.
A bipartisan effort to rein in prescription drug prices advanced Thursday as a key U.S. Senate committee approved a bill aimed at reforming pharmacy benefit managers.

7 Blue-Chip Stocks to Buy in May 2023

06:01pm, Thursday, 04'th May 2023
While large-capitalization enterprises don't offer much excitement, current circumstances may call for the best blue-chip stocks to buy. Frankly, it's getting a little bit toasty on Wall Street, which
Investors looking for stocks in the Large Cap Pharmaceuticals sector might want to consider either Sanofi (SNY) or Eli Lilly (LLY). But which of these two companies is the best option for those lookin

Sanofi SA (SNY) Q1 2023 Earnings Call Transcript

02:27pm, Thursday, 27'th Apr 2023
Sanofi SA (SNY) Q1 2023 Earnings Call Transcript.
Sanofi (SNY) beats first-quarter estimates for earnings but misses the same for sales. Higher sales of Dupixent and rare disease drugs drive Specialty Care GBU sales.

Sanofi backs guidance as it reports higher sales

02:25am, Thursday, 27'th Apr 2023
Corrections & Amplifications
Except the Nasdaq, which snapped a two-day losing streak and was the only major index in the green all day.
We look at a few pharma/biotech companies, SNY, AMGN, REGN, ACAD, which are poised to beat on earnings in the first quarter.
Does Sanofi (SNY) have what it takes to be a top stock pick for momentum investors? Let's find out.
Investors target stocks that have been on a bullish run lately. Stocks like UNM, GPK, SNY and AN that are seeing price strength have a high chance of carrying the momentum forward.
We have screened bargain stocks UNM, SNY, KBH, PVH and VIV based on the EV-to-EBITDA ratio, which offers a clearer picture of valuation and earnings potential.
Sanofi (SNY) possesses solid growth attributes, which could help it handily outperform the market.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE